Biomarkers to Predict Cancer Therapy-related Cardiotoxicity
Biomarkers to Predict Cancer Therapy-related Cardiotoxicity
Recruiting · NCT06353191 · Registry updated 2026-08-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Biomarkers to Predict Cancer Therapy-related Cardiotoxicity | Hematopoietic and Lymphatic System Neoplasm; Malignant Solid Neoplasm | Recruiting | Not stated | 2026-08-18 | NCT06353191 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Mayo Clinic | 970 |
| National Heart, Lung, and Blood Institute (NHLBI) | 791 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mayo Clinic in Arizona | Scottsdale | United States | 191 |
| Mayo Clinic in Florida | Jacksonville | United States | 224 |
| Mayo Clinic in Rochester | Rochester | United States | 687 |
| Moffitt Cancer Center | Tampa | United States | 523 |